AEON Chart
See on advanced chart >
About
AEON Biopharma, Inc. was incorporated in Delaware in February 2012. They are a clinical stage biopharmaceutical company focused on developing the proprietary botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection, or ABP-450, for debilitating medical...
Read More
- HighlightA biopharmaceutical company, develops botulinum toxins for the treatment of debilitating medical conditions
- ExchangeAMEX
- Listing Date07/24/2023
- Established DateInvalid Date
- Full-time Employees10
- Address5 Park Plaza Suite 1750 Irvine California 92614
- Tel1-949-3546499
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals